Cargando…
Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease
Because of the emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different regions of the world, the battle with infectious coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been seesawing. Therefore, the identification of antiviral drugs is of particula...
Autores principales: | Li, Dongsheng, Yan, Gangan, Zhou, Wenwen, Si, Shuyi, Liu, Xiaoping, Zhang, Jing, Li, Yan, Chen, Yunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118179/ https://www.ncbi.nlm.nih.gov/pubmed/35590420 http://dx.doi.org/10.1186/s13578-022-00806-6 |
Ejemplares similares
-
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
por: Chen, Zinuo, et al.
Publicado: (2021) -
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
por: Yan, Gangan, et al.
Publicado: (2021) -
Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro
por: Lü, Jian-Ming, et al.
Publicado: (2012) -
A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors
por: Yan, Haohao, et al.
Publicado: (2022) -
Protocol for high-throughput screening of SARS-CoV-2 main protease inhibitors using a robust fluorescence polarization assay
por: Zhang, Jing, et al.
Publicado: (2022)